Literature DB >> 34739585

Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.

Linda Hertlein1, Thomas Kolben1, Aurelia Vattai2, Nadine Kremer1, Sarah Meister1, Susanne Beyer1, Lucia Keilmann1, Anna Hester1, Mina Temelkov1, Helene Heidegger1, Elisa Schmoeckel3, Mirjana Kessler1, Sven Mahner1, Udo Jeschke1,4.   

Abstract

PURPOSE: Forkhead Box Protein 3 (FoxP3) is known as a key mediator in the immunosuppressive function of regulatory T-cells (Tregs). The aim of our study was to investigate whether FoxP3-positive Tregs have the potential to act as an independent predictor in progression as well as in regression of cervical intraepithelial neoplasia, especially in patients with intermediate cervical intraepithelial neoplasia (CIN II).
METHODS: Nuclear FoxP3 expression was immunohistochemically analysed in 169 patient samples (CIN I, CIN II with regressive course, CIN II with progressive course, CIN III). The median numbers were calculated for each slide and correlated with the histological CIN grade. Statistical analysis was performed by SPSS 26 (Mann-Whitney U test, Spearman's rank correlation).
RESULTS: An increased FoxP3 expression in CIN II with progression could be detected in comparison to CIN II with regression (p = 0.003). Total FoxP3 expression (epithelium and dysplasia-connected stroma) was higher in more advanced CIN grades (p < 0.001 for CIN I vs. CIN II; p = 0.227 for CIN II vs. CIN III). A positive correlation could be detected between FoxP3-positive cells in epithelium and total FoxP3 expression (Spearman's Rho: 0,565; p < 0.01).
CONCLUSION: Expression of FoxP3 could be a helpful predictive factor to assess the risks of CIN II progression. As a prognosticator for regression and progression in cervical intraepithelial lesions it might thereby help in the decision process regarding surgical treatment vs. watchful waiting strategy to prevent conisation-associated risks for patients in child-bearing age. In addition, the findings support the potential of Tregs as a target for immune therapy in cervical cancer patients.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cervical intraepithelial neoplasia; Conisation; FoxP3; HPV; Regulatory T-cells

Mesh:

Substances:

Year:  2021        PMID: 34739585     DOI: 10.1007/s00432-021-03838-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  52 in total

1.  Detection of regulatory T cell phenotypic markers and cytokines in patients with human papillomavirus infection.

Authors:  Camila M Bonin; Cacilda T J Padovani; Izaías P da Costa; Leandro S Ávila; Alda Maria T Ferreira; Carlos Eurico S Fernandes; Andrielli R Dos Santos; Inês Aparecida Tozetti
Journal:  J Med Virol       Date:  2018-09-24       Impact factor: 2.327

2.  Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.

Authors:  Hyun Cheol Chung; Willeke Ros; Jean-Pierre Delord; Ruth Perets; Antoine Italiano; Ronnie Shapira-Frommer; Lyudmila Manzuk; Sarina A Piha-Paul; Lei Xu; Susan Zeigenfuss; Scott K Pruitt; Alexandra Leary
Journal:  J Clin Oncol       Date:  2019-04-03       Impact factor: 44.544

Review 3.  Aetiology, pathogenesis, and pathology of cervical neoplasia.

Authors:  M J Arends; C H Buckley; M Wells
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

4.  HPV16 E7-Driven Epithelial Hyperplasia Promotes Impaired Antigen Presentation and Regulatory T-Cell Development.

Authors:  Abate Assefa Bashaw; Siok M Teoh; Zewen K Tuong; Graham R Leggatt; Ian H Frazer; Janin Chandra
Journal:  J Invest Dermatol       Date:  2019-06-15       Impact factor: 8.551

Review 5.  The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology.

Authors:  Teresa M Darragh; Terence J Colgan; J Thomas Cox; Debra S Heller; Michael R Henry; Ronald D Luff; Timothy McCalmont; Ritu Nayar; Joel M Palefsky; Mark H Stoler; Edward J Wilkinson; Richard J Zaino; David C Wilbur
Journal:  J Low Genit Tract Dis       Date:  2012-07       Impact factor: 1.925

6.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

7.  Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma.

Authors:  Sreenivas Adurthi; Sudhir Krishna; Geetashree Mukherjee; Uttamchand Deepak Bafna; Uma Devi; Rudrapatna Subramanyam Jayshree
Journal:  Am J Reprod Immunol       Date:  2008-07       Impact factor: 3.886

Review 8.  Regulatory T cells and treatment of cancer.

Authors:  Tyler J Curiel
Journal:  Curr Opin Immunol       Date:  2008-05-27       Impact factor: 7.486

9.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.

Authors:  S Chellappan; V B Kraus; B Kroger; K Munger; P M Howley; W C Phelps; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

Review 10.  Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation.

Authors:  Alessandra Colamatteo; Fortunata Carbone; Sara Bruzzaniti; Mario Galgani; Clorinda Fusco; Giorgia Teresa Maniscalco; Francesca Di Rella; Paola de Candia; Veronica De Rosa
Journal:  Front Immunol       Date:  2020-02-03       Impact factor: 7.561

View more
  1 in total

1.  Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma.

Authors:  Sofya Marchenko; Iris Piwonski; Inga Hoffmann; Bruno Valentin Sinn; Catarina Alisa Kunze; Nanna Monjé; Jonathan Pohl; Hagen Kulbe; Wolfgang Daniel Schmitt; Sylvia Darb-Esfahani; Elena Ioana Braicu; Ann-Christin von Brünneck; Jalid Sehouli; Carsten Denkert; David Horst; Korinna Jöhrens; Eliane Tabea Taube
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-28       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.